/ EN

BCIwiki — Brain-computer interface news, research and industry database

Latest

February 2026

ChiCTR Logs Trial of BCI Cognitive Rehab System in Mild Cognitive Impairment

The Chinese Clinical Trial Registry (ChiCTR) has logged a study of a brain-computer interface (BCI)-enabled cognitive rehabilitation system, set to test its clinical effect in patients with mild cognitive impairment. Registered on February 25, 2026 as ChiCTR2600119334, the trial is not yet recruiting.
Why it matters A first-in-China registration in mild cognitive impairment stretches the clinical case for BCI beyond motor recovery into cognition, where a non-drug option would carry real weight and the evidence base is still thin.

Children With Cerebral Palsy Show Keen Interest in BCI-Controlled Boccia Ramp

Researchers designed an assistive Boccia ramp controlled by a brain-computer interface so that children with severe motor impairments who cannot speak can take part in the Paralympic sport. Six caregivers took part in semi-structured interviews and six children completed a newly developed 21-item survey; the children showed keen interest in playing Boccia with a BCI. The study also maps current barriers and facilitators to sport participation, and the issues that must be resolved before such technology can be rolled out.
Why it matters Rather than stopping at whether the device works, the team first asked its intended users, six children with quadriplegic cerebral palsy and their caregivers, what they thought of BCI-assisted Boccia; the children clearly wanted to use it and caregivers saw promise, but the paper also lists the barriers to real-world use, making it an early, user-side needs list for pediatric rehabilitation and assistive technology, drawn from just 12 people and with no data yet on actual use.

Improved Spontaneous EEG Signal Decoding Efficiency by Function Predefined Convolutional Neural Network

Researchers propose a function predefined convolutional neural network (FPCNN) for decoding spontaneous EEG in brain-computer interfaces. Its learnable function predefined convolution (FPC) layer searches for the key spatial-frequency parameters of spontaneous EEG so the parameters carry clear physical meaning, and it builds trainable orthogonal detectors on the FPC to capture complex phase-varying signals. On three spontaneous EEG datasets, FPCNN outperformed state-of-the-art methods by 2.09%, 3.08% and 3.41%, with single-round training and testing taking just 67.96 and 19.36 seconds on non-GPU hardware, which the authors say makes it suited to EEG processing in diverse environments.
Why it matters The combination — modest gains over state-of-the-art plus CPU-only training and testing measured in seconds — points to a decoder cheap enough to run in resource-limited or edge settings, a practical constraint that accuracy-focused EEG papers rarely address.

EEG-Based Emotion Recognition Using Spatial-Temporal Graph-Aware Network With Channel Selection

The study presents an EEG emotion recognition framework that couples discriminative channel selection with hierarchical spatial-temporal modeling. Wavelet coherence and mutual information adaptively select informative channels across frequency bands, and a spatial-temporal graph-aware network (STG-Net) models inter-channel spatial relations and the temporal evolution of emotional states before fusing frequency-spatial-temporal features for classification. The authors report better recognition accuracy and model efficiency than state-of-the-art methods.
Why it matters Band-adaptive channel selection — rather than the uniform rules used before — attacks the redundancy and compute cost that have kept real-time EEG emotion recognition out of interactive systems.

FDA Clears PreOp v3 Source Localization Tool

The FDA cleared Clouds of Care's PreOp v3 on February 13, 2026, finding it substantially equivalent under submission number K252565 through the special 510(k) pathway. The agency classifies it as Source Localization Software for Electroencephalograph or Magnetoencephalograph, a Class II device under regulation 882.1400, with neurology as the assigned review panel. Source localization software infers the intracranial origin of signals from scalp-recorded electric or magnetic fields, a step in neurosurgical planning such as presurgical localization of epileptic foci.
Why it matters Presurgical epilepsy planning is one of the few settings where a scalp-derived source estimate is later checked against what surgeons find inside the skull, which makes cleared localization software a useful reference point for how far noninvasive spatial resolution can be pushed.

Layer 7 Array Decodes Speech and Cursor Direction in Four Surgical Patients

A Neurosurgical Focus paper tested Precision Neuroscience's 1,024-channel Layer 7 micro-ECoG array in four awake-craniotomy patients. Four-word speech classification reached 77.5% accuracy and four-direction cursor classification reached 78% to 84%, with no device-related adverse events reported during the procedures. The small, short intraoperative study was a feasibility test rather than a pivotal motor-restoration trial.
Why it matters Real-time speech and motor decoding from the same surface array shows platform breadth, while the intraoperative design prevents any claim about chronic therapeutic benefit.
January 2026

Neuralink Expands Its Global BCI Trial Cohort to 21 Participants

Neuralink said its clinical trials worldwide now include 21 participants. After making surgical and postoperative changes in response to thread retraction in the first recipient, the company reported higher signal quality in 18 of the next 20 participants. The figures come from a company update rather than a peer-reviewed clinical report.
Why it matters A cohort of 21 begins to test whether Neuralink's performance can hold across different anatomies and conditions, while long-term safety and complete follow-up data remain unresolved.

BCI Advances Could Solve Olfactory Implant Electrode Challenges

Researchers discuss how recent BCI advances in electrode longevity and biocompatibility could address key olfactory implant challenges.
Why it matters Olfactory implants represent an emerging BCI application. This paper connects BCI electrode advances with olfactory implant challenges, offering a cross-disciplinary technology transfer perspective.

Researchers Say BCIs Should Decode User Goals, Not Motor Cortex Signals

Researchers in Germany, the Netherlands and Japan argue in an opinion piece that brain-computer interface design should be rebuilt around ideomotor theory, which treats voluntary action as driven by internally represented sensory outcomes. BCI research has made remarkable technical progress but remains limited in scope, the authors write, typically relying on motor and visual cortex signals in a narrow range of patient populations, and they describe this underused framework as a principled basis for next-generation interfaces that align more closely with the brain's own intentional and action-planning architecture. Reorganizing BCIs around the purpose of an action, meaning the user's goals and anticipated effects, would be a more intuitive, generalizable and scalable path, they suggest, and advances in neural recording and artificial intelligence-based decoding of sensory representations make the shift feasible and timely, potentially easing persistent usability and generalizability problems in BCI design.
Why it matters The argument targets an assumption most of the field treats as settled, that a BCI should read out intended movements from motor cortex. Decoding the anticipated outcome instead would change what counts as a decoding target, what training data is needed, and how systems are evaluated, which is a heavier lift than it sounds. This is a perspective article rather than an empirical result, and the authors offer no implementation.

NeuroXess Breaks Ground on BCI Factory Targeting 10,000-Unit Supply

NeuroXess broke ground on a roughly 14,300-square-meter BCI manufacturing project in Jiangxi province in eastern China. The company said the facility would produce flexible implantable electrodes, neural recording equipment, surgical robots and fully implanted wireless BCI systems, with a target of stable supply at the 10,000-unit scale. NeuroXess expects the factory to begin operating in the second half of 2026, but the capacity and timeline remain company projections.
Why it matters The project moves China's implantable BCI race into manufacturing validation, where on-time commissioning and medical-device quality compliance will matter more than announced capacity.

© 2026 BCIwiki.com Digest Topics Tips Subscribe Revisions About